The FDA approved a new drug for hot flashes. Here's why it shows 'a lot of promise'
The Food and Drug Administration last Friday approved fezolinetant, or Veozah, to treat hot flashes for women in menopause. The non-hormonal drug treatment is the first of its class and represents an option for women who cannot take hormones.
Tribune News Service ·